82.7 F
New York
Friday, July 30, 2021

AnPac Bio [NASDAQ: ANPC] Exhibits That Its CDA Technology Is Sensitive To Identifying Pre-cancer Diseases

Must read

Ucommune [NASDAQ: UK] Ink Cooperation Agreement with Beijing Investment Group

Ucommune International Ltd. inked a cooperation agreement with Beijing Investment Group Co., LTD. Beijing Investment is a fully state-owned land developer associated with...

Lion Electric [NYSE: LEV] all Set to Deliver Two Electric Trucks to Green Mountain Power

The Lion Electric Company revealed on Friday that it is preparing to deliver two of its all-electric trucks to Green Mountain Power (GMP)...

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

AnPac Bio-Medical Sciences Co [NASDAQ: ANPC] revealed that the company has made substantial improvements in identifying pre-cancer diseases. AnPac made progress through a novel sensor design, sensor fabrication detection process, etc. The company recently completed the testing of 110,000 people through its Cancer Differentiation Analysis Technology.

Moreover, Its follow up study involved the evaluation of 13000 people with high, medium, and low cancer risk using CDA technology.  The first phase results of the study revealed that technology is competent in delivering useful information. It is also useful for detecting pre-cancer diseases. The technology screened 20 types of pre-cancer diseases with Thyroid tumor ranking 1 and Pulmonary tumor ranking 2.

Out of the 13,000 people, AnPac screened out and affirmed pre-malignancy cases at generally 4.5 occasions of that of cancer growth cases, firmly exhibiting that AnPac Bio CDA innovation is capable of identifying pre-cancer diseases and it could play a vital role in disease inhibition

More articles

Latest article

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...